Shin‐ichi Harashima
- Molecular Biology top 10%
- Immunology top 5%
- Endocrinology, Diabetes and Metabolism top 1%
- Rheumatology top 2%
- Surgery top 10%
- Co-authors
- Takahiko HoriuchiHiroshi TsukamotoHiroki MitomaT. ShimodaNobuya InagakiJulie Derving KarsbølChristopher SorliGeorge Tsoukas
- Topics
- Diabetes Treatment and Management (17 papers)Diabetes Management and Research (15 papers)Pancreatic function and diabetes (13 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Shin‐ichi Harashima
67 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 944
- Immunology 834
- Endocrinology, Diabetes and Metabolism 782
- Rheumatology 457
- Surgery 425
Countries citing papers authored by Shin‐ichi Harashima
This map shows the geographic impact of Shin‐ichi Harashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin‐ichi Harashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin‐ichi Harashima more than expected).
Fields of papers citing papers by Shin‐ichi Harashima
This network shows the impact of papers produced by Shin‐ichi Harashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin‐ichi Harashima. The network helps show where Shin‐ichi Harashima may publish in the future.
Co-authorship network of co-authors of Shin‐ichi Harashima
This figure shows the co-authorship network connecting the top 25 collaborators of Shin‐ichi Harashima. A scholar is included among the top collaborators of Shin‐ichi Harashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin‐ichi Harashima. Shin‐ichi Harashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trialbreakdown → | 496 |
| 4 | 7 | |
| 5 | 60 | |
| 6 | 16 | |
| 7 | 63 | |
| 8 | 27 | |
| 9 | 16 | |
| 10 | 6 | |
| 11 | 30 | |
| 12 | 17 | |
| 13 | 36 | |
| 14 | 15 | |
| 15 | 20 | |
| 16 | 20 | |
| 17 | 1 | |
| 18 | 40 | |
| 19 | 106 | |
| 20 | 39 |
About Shin‐ichi Harashima
Shin‐ichi Harashima is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Rheumatology, having authored 69 papers that have together received 2.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (17 papers), Diabetes Management and Research (15 papers) and Pancreatic function and diabetes (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (782 citations), Immunology (834 citations) and Rheumatology (457 citations). Shin‐ichi Harashima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takahiko Horiuchi, Hiroshi Tsukamoto, Hiroki Mitoma, T. Shimoda, Nobuya Inagaki, Julie Derving Karsbøl, Christopher Sorli, George Tsoukas, Jeffrey Unger and Stephen C. Bain. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.